Cargando…

Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase

BACKGROUND: Repair deficiency after endometrial injury is an important reason for intra-uterine adhesions, amenorrhea, and infertility in females. Bone marrow-derived mesenchymal stem cell (BMSC) transplantation is effective in repairing the damaged endometrium. However, the possibility of using umb...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lu, Li, Ying, Guan, Chun-Yi, Tian, Shi, Lv, Xiao-Dan, Li, Jian-Hui, Ma, Xu, Xia, Hong-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810045/
https://www.ncbi.nlm.nih.gov/pubmed/29433563
http://dx.doi.org/10.1186/s13287-018-0777-5
_version_ 1783299674565771264
author Zhang, Lu
Li, Ying
Guan, Chun-Yi
Tian, Shi
Lv, Xiao-Dan
Li, Jian-Hui
Ma, Xu
Xia, Hong-Fei
author_facet Zhang, Lu
Li, Ying
Guan, Chun-Yi
Tian, Shi
Lv, Xiao-Dan
Li, Jian-Hui
Ma, Xu
Xia, Hong-Fei
author_sort Zhang, Lu
collection PubMed
description BACKGROUND: Repair deficiency after endometrial injury is an important reason for intra-uterine adhesions, amenorrhea, and infertility in females. Bone marrow-derived mesenchymal stem cell (BMSC) transplantation is effective in repairing the damaged endometrium. However, the possibility of using umbilical cord-derived MSCs (UC-MSCs) to treat endometrial injury is rarely reported. METHODS: Ethanol (95%) was injected into rat uterus to establish a model of endometrial injury. UC-MSCs were injected through the tail vein, either as a single, twice, or thrice administration. Functional restoration of the uterus was assessed by testing embryo implantation rates. Endometrial morphological alteration was observed by hematoxylin and eosin staining. Endometrial fibrosis, markers of epithelial and stromal cells of endometrium, cell proliferation and angiogenesis, and inflammatory factors were detected using immunohistochemistry, Western blotting, and quantitative reverse-transcription polymerase chain reaction. RESULTS: Endometrial morphology and embryo implantation rates were significantly improved on day 8 of transplantation among single-, twice-, or thrice-administered rats. Moreover, UC-MSCs could alleviate fibrosis in general, and reduced the expression of fibrosis markers, α-smooth muscle actin (α-SMA) and transforming growth factor (TGF)-β. The cell proliferation marker Ki-67 had a positive expression in the injured endometrium after UC-MSC transplantation. The endometrial stromal marker vimentin and epithelial marker cytokeratin-19 (CK-19) expressions were visibly increased. The expression of vascular markers CD31, vascular endothelial growth factor (VEGF)A, and matrix metalloprotein (MMP)9 was generally upregulated. Proinflammatory factors interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and interleukin (IL)-2 were significantly downregulated in the rats administered UC-MSCs twice and thrice. CONCLUSIONS: UC-MSC transplantation contributed to the repair of endometrial injury and restoration of fertility, likely through the suppression of excessive fibrosis and inflammation, and enhancement of endometrial cell proliferation and vascular remodeling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13287-018-0777-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5810045
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58100452018-02-16 Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase Zhang, Lu Li, Ying Guan, Chun-Yi Tian, Shi Lv, Xiao-Dan Li, Jian-Hui Ma, Xu Xia, Hong-Fei Stem Cell Res Ther Research BACKGROUND: Repair deficiency after endometrial injury is an important reason for intra-uterine adhesions, amenorrhea, and infertility in females. Bone marrow-derived mesenchymal stem cell (BMSC) transplantation is effective in repairing the damaged endometrium. However, the possibility of using umbilical cord-derived MSCs (UC-MSCs) to treat endometrial injury is rarely reported. METHODS: Ethanol (95%) was injected into rat uterus to establish a model of endometrial injury. UC-MSCs were injected through the tail vein, either as a single, twice, or thrice administration. Functional restoration of the uterus was assessed by testing embryo implantation rates. Endometrial morphological alteration was observed by hematoxylin and eosin staining. Endometrial fibrosis, markers of epithelial and stromal cells of endometrium, cell proliferation and angiogenesis, and inflammatory factors were detected using immunohistochemistry, Western blotting, and quantitative reverse-transcription polymerase chain reaction. RESULTS: Endometrial morphology and embryo implantation rates were significantly improved on day 8 of transplantation among single-, twice-, or thrice-administered rats. Moreover, UC-MSCs could alleviate fibrosis in general, and reduced the expression of fibrosis markers, α-smooth muscle actin (α-SMA) and transforming growth factor (TGF)-β. The cell proliferation marker Ki-67 had a positive expression in the injured endometrium after UC-MSC transplantation. The endometrial stromal marker vimentin and epithelial marker cytokeratin-19 (CK-19) expressions were visibly increased. The expression of vascular markers CD31, vascular endothelial growth factor (VEGF)A, and matrix metalloprotein (MMP)9 was generally upregulated. Proinflammatory factors interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and interleukin (IL)-2 were significantly downregulated in the rats administered UC-MSCs twice and thrice. CONCLUSIONS: UC-MSC transplantation contributed to the repair of endometrial injury and restoration of fertility, likely through the suppression of excessive fibrosis and inflammation, and enhancement of endometrial cell proliferation and vascular remodeling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13287-018-0777-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-13 /pmc/articles/PMC5810045/ /pubmed/29433563 http://dx.doi.org/10.1186/s13287-018-0777-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhang, Lu
Li, Ying
Guan, Chun-Yi
Tian, Shi
Lv, Xiao-Dan
Li, Jian-Hui
Ma, Xu
Xia, Hong-Fei
Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase
title Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase
title_full Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase
title_fullStr Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase
title_full_unstemmed Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase
title_short Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase
title_sort therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810045/
https://www.ncbi.nlm.nih.gov/pubmed/29433563
http://dx.doi.org/10.1186/s13287-018-0777-5
work_keys_str_mv AT zhanglu therapeuticeffectofhumanumbilicalcordderivedmesenchymalstemcellsoninjuredratendometriumduringitschronicphase
AT liying therapeuticeffectofhumanumbilicalcordderivedmesenchymalstemcellsoninjuredratendometriumduringitschronicphase
AT guanchunyi therapeuticeffectofhumanumbilicalcordderivedmesenchymalstemcellsoninjuredratendometriumduringitschronicphase
AT tianshi therapeuticeffectofhumanumbilicalcordderivedmesenchymalstemcellsoninjuredratendometriumduringitschronicphase
AT lvxiaodan therapeuticeffectofhumanumbilicalcordderivedmesenchymalstemcellsoninjuredratendometriumduringitschronicphase
AT lijianhui therapeuticeffectofhumanumbilicalcordderivedmesenchymalstemcellsoninjuredratendometriumduringitschronicphase
AT maxu therapeuticeffectofhumanumbilicalcordderivedmesenchymalstemcellsoninjuredratendometriumduringitschronicphase
AT xiahongfei therapeuticeffectofhumanumbilicalcordderivedmesenchymalstemcellsoninjuredratendometriumduringitschronicphase